SCHEMBL18573258

SCHEMBL18573258

N#Cc1cc(-c2ccccc2-c2ccc(-c3ccccc3)nc2)cc(-c2ccccc2-c2ccc(-c3ccccc3)nc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 4/20 0.46
GABRB3 P28472 4/20 0.46
GABRA5 P31644 4/20 0.46
GABRA3 P34903 4/20 0.46
GABRA1 P14867 2/20 0.46
KDM1A O60341 2/20 0.42
ALDH1A1 P00352 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LDHA P00338 1/20 0.41
HPGDS O60760 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
METAP2 P50579 1/20 0.40
ALDH1A3 P47895 1/20 0.40
GRM5 P41594 2/20 0.40
MAOB P27338 1/20 0.40
PDK2 Q15119 1/20 0.39
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015574 0.87 LDHA (0.52) LDHAHPGDSHSD17B1HSD17B2FEN1
SCHEMBL19933578 0.87 LDHA (0.52) LDHAHPGDSHSD17B1HSD17B2FEN1
SCHEMBL23239876 0.86 GRM5 (0.44) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL21721920 0.85 LDHA (0.50) LDHAHPGDSHSD17B1HSD17B2FEN1
SCHEMBL19794431 0.85 LDHA (0.50) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL18015495 0.85 LDHA (0.50) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL19794370 0.85 LDHA (0.50) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL21125931 0.84 HSD17B1 (0.56) LDHAHPGDSHSD17B1HSD17B2FEN1
SCHEMBL19801366 0.83 CLK4 (0.46) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL19933728 0.82 LDHA (0.47) LDHAHPGDSHSD17B1HSD17B2ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11031562-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-08 US disclosed
WO-2017032439-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11031562-B2 Metal complexes AP1M1, SOD1, AP3M1 GABRG2 2032/4885GABRB3 1804/4885GABRA5 2020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.